AAAAAA

   
Results: 1-7 |
Results: 7
In vitro topo II-DNA complex accumulation and cytotoxicity of etoposide inleukaemic cells from patients with acute myelogenous and chronic lymphocytic leukaemia
Authors: Wang, YY Zhou, R Liliemark, J Gruber, A Lindemalm, S Albertioni, F Liliemark, E
Citation: Yy. Wang et al., In vitro topo II-DNA complex accumulation and cytotoxicity of etoposide inleukaemic cells from patients with acute myelogenous and chronic lymphocytic leukaemia, LEUK RES, 25(2), 2001, pp. 133-140
P-glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with p-glycoprotein-positive acute myeloid leukemia
Authors: Tidefelt, U Liliemark, J Gruber, A Liliemark, E Sundman-Engberg, B Juliusson, G Stenke, L Elmhorn-Rosenborg, A Mollgard, L Lehman, S Xu, D Covelli, A Gustavsson, B Paul, C
Citation: U. Tidefelt et al., P-glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with p-glycoprotein-positive acute myeloid leukemia, J CL ONCOL, 18(9), 2000, pp. 1837-1844
Distribution of 2-chloro-2 '-deoxyadenosine, 2-chloro-2 '-arabino-fluoro-2'-deoxyadenosine, Fludarabine and Cytarabine in mice: a whole-body autoradiography study
Authors: Lindemalm, SN Liliemark, J Larsson, BS Albertioni, F
Citation: Sn. Lindemalm et al., Distribution of 2-chloro-2 '-deoxyadenosine, 2-chloro-2 '-arabino-fluoro-2'-deoxyadenosine, Fludarabine and Cytarabine in mice: a whole-body autoradiography study, MED ONCOL, 16(4), 1999, pp. 239-244
Biochemical pharmacology and resistance to 2-chloro-2 '-arabinonuoro-2 '-deoxyadenosine, a novel analogue of cladribine in human leukemic cells
Authors: Lotfi, K Mansson, E Spasokoukotskaja, T Pettersson, B Liliemark, J Peterson, C Eriksson, S Albertioni, F
Citation: K. Lotfi et al., Biochemical pharmacology and resistance to 2-chloro-2 '-arabinonuoro-2 '-deoxyadenosine, a novel analogue of cladribine in human leukemic cells, CLIN CANC R, 5(9), 1999, pp. 2438-2444
Etoposide-induced DNA strand breaks in relation to p-glycoprotein and topoisomerase II protein expression in leukaemic cells from patients with AML and CLL
Authors: Zhou, R Vitols, S Gruber, A Liliemark, J Wang, Y Liliemark, E
Citation: R. Zhou et al., Etoposide-induced DNA strand breaks in relation to p-glycoprotein and topoisomerase II protein expression in leukaemic cells from patients with AML and CLL, BR J HAEM, 105(2), 1999, pp. 420-427
Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma
Authors: Celsing, E Widell, S Merk, K Bernell, P Grimfors, G Hedlund, A Liliemark, J Svedmyr, E Osby, E Bjorkholm, M
Citation: E. Celsing et al., Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma, ANN ONCOL, 9(11), 1998, pp. 1213-1217
Multidrug resistance phenotype in leukaemic cells from patients with acutemyelocytic leukaemia can be detected with Tc-99(m)-MIBI
Authors: Gruber, A Arestrom, I Xu, D Liliemark, J Larsson, SA Jacobsson, H
Citation: A. Gruber et al., Multidrug resistance phenotype in leukaemic cells from patients with acutemyelocytic leukaemia can be detected with Tc-99(m)-MIBI, BR J CANC, 77(11), 1998, pp. 1732-1736
Risultati: 1-7 |